Topical Arnica and Mucopolysaccharide Polysulfate on Postoperative Pain, Edema and Trismus

• Status: Completed
• Trial end date: 2020-01-30
• Target enrollment: 0
• Participant gender: All

Summary

The present study was to evaluate the effect of topical Arnica and MPSP application with respect to visual analogue scale (VAS) scores, maximal interincisal opening (MIO) and edema values after mandibular impacted third molar removal on days 1, 3, 5 and 10 postoperatively. The following null hypotheses of the present research were determined as follows: usage of topical agents would not influence i) VAS scores, ii) MIO values, and iii) edema values on 1st, 3rd, 5th, and 10th days after the mandibular impacted third molar surgery

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Abant Izzet Baysal University

Criteria

Inclusion Criteria:

• Age between 16-68 years

• American Society of Anesthesiologists (ASA) Class 1 physiological status

• Consistent radiological and clinical data

• Volunteered to participate in the study

• Scale II" surgery difficulty according to Modified Parant Classification for mandibular impacted third molar removal, be free of pericoronitis and infection at operation time

Exclusion Criteria:

• Being out of age range

• Pregnancy or lactation

• Analgesic or antibiotic therapy history in last 14 days due to symptoms of related third molar

• Smoking cigarette

• Any pathology associated with impacted third molar

• Active complaints on preoperative examination on the day of surgery

• Immunosuppressed or diagnosed with malignancy

• Diagnosed chronic diseases such as; Diabetes mellitus (DM), hypertension, cerebrovascular event, psychiatric diseases, coagulopathies

• Autoimmune diseases

• Patients who could not attend regular follow-up visits

• Allergy to the medications prescribed or utilized in study protocol

• Inconsistent clinical and radiological data or missed follow-up